Zydus Lifesciences Ltd

ZYDUSLIFE

Company Profile

  • Business description

    Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. It is engaged in the research, development, production, marketing, and distribution of pharmaceutical products. The product portfolio of the company includes Active Pharmaceutical Ingredients (API), human formulations, animal health and veterinary, and consumer health and wellness products. Its products are marketed under brands like Amlodac, Inditel, Pivasta, and others. The company's operating segments are: Pharmaceuticals, which derives key revenue, and Consumer products. Geographically, it generates maximum revenue from the United States, followed by India, and other countries.

  • Contact

    Scheme No. 63, Sarkhej-Gandhinagar Highway
    Zydus Corporate Park, Survey No. 536
    Near Vaishnodevi Circle
    Khoraj (Gandhinagar)
    AhmedabadGJ382481
    IND

    T: +91 7971800000

    https://www.zyduslife.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    27,917

Stocks News & Analysis

stocks

Fears of deteriorating loan quality sends bank share plummeting

We maintain our fair value estimate despite unfavourable economic conditions.
stocks

Why it’s not all bad news for Flight Centre following downgrade

Despite an earnings downgrade, shares in FLT remain undervalued.
stocks

Chart of the Week: What 650 IPOs reveal about long-term performance

Our data shows buying into the IPO hype can be costly.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,964.201.20-0.01%
CAC 408,384.8746.74-0.55%
DAX 4024,671.22323.61-1.29%
Dow JONES (US)51,876.1144.51-0.09%
FTSE 10010,508.0221.87-0.21%
HKSE22,671.86405.05-1.76%
NASDAQ25,297.6260.99-0.24%
Nikkei 22569,360.883,005.46-4.15%
NZX 50 Index13,495.242.190.02%
S&P 5007,354.023.47-0.05%
S&P/ASX 2008,764.200.200.00%
SSE Composite Index4,027.2693.02-2.26%

Market Movers